Physician profile
Christopher Bauer
NPI 1437123254
$38,440.73
in general payments reported to CMS, 2019-2025
28 companies · $8,029 in 2025
The $8,029 reported for 2025 was more than what 76% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,324 · 2020: $1,379 · 2021: $1,706 · 2022: $5,045 · 2023: $4,132 · 2024: $12K · 2025: $8,029.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $17K · Travel and Lodging: $4,952 · Consulting Fee: $2,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $17,034.84 |
| Travel and Lodging | $4,952.48 |
| Consulting Fee | $2,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $11,447.04 | 2019-2025 | Aveir, Ensite, Jot Dx |
| Medtronic, INC. | $8,931.04 | 2021-2025 | Micra, Aurora Ev-Icd Mri Surescan, Cobalt Dr Mri Surescan |
| Biotronik INC. | $6,934.50 | 2022-2025 | Acticor 7 Vr-T Dx, Biomonitor, Amvia Edge |
| Boston Scientific Corporation | $3,745.09 | 2019-2025 | Farapulse, General - Therapies, Watchman Access System |
| Medtronic Vascular, INC. | $3,353.15 | 2019-2020 | |
| Biosense Webster, INC. | $2,050.88 | 2019-2025 | Carto 3, Qdot Micro Catheter, Qdot Micro |
| Cvrx, INC. | $1,216.04 | 2022-2025 | Barostim Neo System |
| Impulse Dynamics (USA) INC. | $146.49 | 2022 | |
| Atricure, INC. | $93.74 | 2022 | |
| Novo Nordisk INC | $74.85 | 2021-2024 | |
| Cardiva Medical, INC. | $70.02 | 2021 | |
| Lilly USA, LLC | $55.56 | 2023-2024 | Jardiance |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $38.53 | 2022-2023 | Lifevest |
| Abbvie INC. | $31.84 | 2025 | |
| Kowa Pharmaceuticals America, INC. | $27.93 | 2021 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $23.43 | 2023 | Repatha |
| Dentsply Sirona INC | $21.68 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $21.25 | 2022 | |
| Seqirus USA INC | $20.59 | 2024 | Fluad, Flucelvax |
| Novartis Pharmaceuticals Corporation | $19.78 | 2024 | |
| Axsome Therapeutics, INC. | $19.37 | 2024 | Auvelity |
| Astrazeneca Pharmaceuticals Lp | $16.25 | 2025 | Airsupra |
| Vertex Pharmaceuticals Incorporated | $16.10 | 2025 | |
| Genentech USA, INC. | $15.16 | 2019 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $13.93 | 2025 | Caplyta |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.37 | 2019 | |
| Eisai INC. | $12.26 | 2021 | |
| Ge Healthcare | $10.86 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Bauer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.